Введение
На этой странице представлен всесторонний анализ известной истории инсайдерской торговли Michael Parini. Инсайдеры — это должностные лица, директора или крупные инвесторы компании. Инсайдерам запрещено совершать сделки в своих компаниях на основе конкретной, закрытой информации. Это не означает, что для них незаконно совершать какие-либо сделки в своих собственных компаниях. Однако они должны сообщать обо всех сделках в SEC по форме 4. Несмотря на эти ограничения, академические исследования показывают, что инсайдеры в целом имеют тенденцию опережать рынок в своих собственных компаниях.
Средняя прибыльность торговли
Средняя прибыльность торговли — это средний доход от всех покупок на открытом рынке, сделанных инсайдером за последние три года. Чтобы рассчитать это, мы проверяем каждую незапланированную покупку инсайдера на открытом рынке, исключая все сделки, которые были отмечены как часть торгового плана 10b5-1. Затем мы рассчитываем среднюю эффективность этих сделок за 3, 6 и 12 месяцев, усредняя каждую из этих продолжительностей, чтобы получить окончательный показатель эффективности для каждой сделки. Наконец, мы усредняем все показатели производительности, чтобы рассчитать показатель производительности для инсайдера. В этот список включены только инсайдеры, совершившие не менее трех сделок за последние два года.
Если прибыльность этой инсайдерской сделки равна «Н/Д», то инсайдер либо не совершал никаких покупок на открытом рынке за последние три года, либо совершенные им сделки слишком недавние, чтобы можно было рассчитать надежные показатели эффективности.
Частота обновлений: ежедневно
Компании с заявленной инсайдерской позицией
В документах SEC указано, что Michael Parini сообщил о владениях или сделках со следующими компаниями:
Безопасность | Заголовок | Последние зарегистрированные холдинги |
---|---|---|
US:VRTX / Vertex Pharmaceuticals Incorporated | EVP, Chief Adm, Leg & BD Off | 30 837 |
Как интерпретировать графики
На следующих диаграммах показаны динамика акций ценных бумаг после каждой незапланированной сделки на открытом рынке, совершенной Michael Parini. Незапланированная сделка — это сделка, которая не была совершена в рамках торгового плана 10b5-1. Динамика акций отображается как совокупное процентное изменение цены акций. Например, если инсайдерская сделка была совершена 1 января 2019 года, на графике будет показано дневное процентное изменение ценной бумаги к текущему дню. Если бы цена акций за это время выросла с 10 до 15 долларов, совокупное процентное изменение цены акций составило бы 50%. Изменение цены с 10 до 20 долларов составит 100%, а изменение цены с 10 до 5 долларов составит -50%.
В конечном счете, мы пытаемся определить, насколько тесно инсайдерские сделки коррелируют с избыточной доходностью (положительной или отрицательной) от цены акций, чтобы увидеть, рассчитывает ли инсайдер свои сделки для получения прибыли от инсайдерской информации. Рассмотрим ситуацию, когда это делал инсайдер. В этой ситуации мы ожидаем либо (а) положительной прибыли после покупок, либо (б) отрицательной прибыли после продажи. В случае (а) график ПОКУПКИ покажет серию восходящих кривых, указывающих на положительную доходность после каждой транзакции покупки. В случае (b) график ПРОДАЖИ будет отображать серию нисходящих кривых, указывающих на отрицательную доходность после каждой транзакции продажи.
Однако одного этого недостаточно, чтобы делать выводы. Если, например, цена акций компании росла нециклически в течение многих лет, то мы ожидаем, что все графики после покупки будут иметь наклон вверх. Аналогичным образом, нециклическое снижение на протяжении многих лет приведет к нисходящему наклону постторговых графиков. Ни один из этих графиков не указывает на инсайдерскую торговую активность.
Самым сильным индикатором была бы ситуация, когда цена акций была чрезвычайно цикличной, и были как положительные сигналы на графике ПОКУПКИ, так и отрицательные участки на графике ПРОДАЖИ. Эта ситуация весьма наводит на мысль о том, что инсайдер рассчитывает сделку в свою финансовую выгоду.
История инсайдерской торговли
В этой таблице показан полный список инсайдерских сделок, совершенных Michael Parini, раскрытый Комиссии по ценным бумагам и биржам (SEC).
Дата файла | Тран Дата | Форма | Бегущая строка | Безопасность | Код | Акции | Оставшиеся акции | Процент Изменять |
Делиться Цена |
Тран Ценить |
Оставшийся Ценить |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2021-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -354 | 30 837 | -1,13 | 216,26 | -76 556 | 6 668 810 |
2021-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -680 | 31 191 | -2,13 | 214,28 | -145 710 | 6 683 607 |
2021-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 348 | 31 871 | -4,06 | 213,04 | -287 178 | 6 789 798 |
2021-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -646 | 33 219 | -1,91 | 211,58 | -136 681 | 7 028 476 |
2021-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | -2 416 | 33 865 | -6,66 | 217,57 | -525 649 | 7 368 008 | |
2021-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -200 | 36 281 | -0,55 | 213,45 | -42 690 | 7 744 179 |
2021-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 952 | 36 481 | -5,08 | 212,56 | -414 917 | 7 754 401 |
2021-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -4 666 | 38 433 | -10,83 | 211,83 | -988 399 | 8 141 262 |
2021-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 007 | 43 099 | -2,28 | 210,08 | -211 551 | 9 054 238 |
2021-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | -6 240 | 44 106 | -12,39 | 211,75 | -1 321 320 | 9 339 446 | |
2021-02-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -200 | 50 346 | -0,40 | 211,97 | -42 394 | 10 671 842 |
2021-02-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -300 | 50 546 | -0,59 | 211,21 | -63 363 | 10 675 821 |
2021-02-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -3 818 | 50 846 | -6,98 | 210,43 | -803 422 | 10 699 524 |
2021-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | -2 563 | 54 664 | -4,48 | 214,16 | -548 892 | 11 706 842 | |
2021-02-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | -1 930 | 0 | -100,00 | ||||
2021-02-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 930 | 57 227 | -3,26 | 215,00 | -414 950 | 12 303 805 |
2021-02-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 930 | 59 157 | 3,37 | 86,52 | 166 984 | 5 118 264 | |
2021-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to buy) |
M - Exercise | -400 | 1 930 | -17,17 | ||||
2021-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -100 | 57 227 | -0,17 | 218,20 | -21 820 | 12 486 931 |
2021-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -100 | 57 327 | -0,17 | 217,00 | -21 700 | 12 439 959 |
2021-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -200 | 57 427 | -0,35 | 215,52 | -43 104 | 12 376 667 |
2021-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 400 | 57 627 | 0,70 | 86,52 | 34 608 | 4 985 888 | |
2021-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 11 627 | 57 227 | 25,50 | ||||
2021-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 10 324 | 45 600 | 29,27 | ||||
2021-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 8 438 | 35 276 | 31,44 | ||||
2020-11-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -25 | 26 838 | -0,09 | 224,34 | -5 608 | 6 020 837 |
2020-11-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -40 | 26 863 | -0,15 | 223,67 | -8 947 | 6 008 447 |
2020-11-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -26 | 26 903 | -0,10 | 222,52 | -5 786 | 5 986 456 |
2020-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -2 330 | 2 330 | -50,00 | ||||
2020-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -200 | 26 838 | -0,74 | 221,25 | -44 250 | 5 937 908 |
2020-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -300 | 27 038 | -1,10 | 220,10 | -66 030 | 5 951 064 |
2020-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -600 | 27 338 | -2,15 | 218,63 | -131 178 | 5 976 907 |
2020-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -600 | 27 938 | -2,10 | 217,20 | -130 320 | 6 068 134 |
2020-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -630 | 28 538 | -2,16 | 215,16 | -135 551 | 6 140 236 |
2020-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 330 | 29 168 | 8,68 | 86,52 | 201 592 | 2 523 615 | |
2020-08-10 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -1 223 | 7 338 | -14,29 | ||||
2020-08-10 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -311 | 26 838 | -1,15 | 272,53 | -84 757 | 7 314 160 |
2020-08-10 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -422 | 27 149 | -1,53 | 271,45 | -114 552 | 7 369 596 |
2020-08-10 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -490 | 27 571 | -1,75 | 270,13 | -132 364 | 7 447 754 |
2020-08-10 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 223 | 28 061 | 4,56 | 155,57 | 190 262 | 4 365 450 | |
2020-08-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -2 330 | 4 660 | -33,33 | ||||
2020-08-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -730 | 26 838 | -2,65 | 279,41 | -203 969 | 7 498 806 |
2020-08-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 100 | 27 568 | -3,84 | 278,13 | -305 943 | 7 667 488 |
2020-08-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -500 | 28 668 | -1,71 | 276,98 | -138 490 | 7 940 463 |
2020-08-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 330 | 29 168 | 8,68 | 86,52 | 201 592 | 2 523 615 | |
2020-07-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -2 125 | 0 | -100,00 | ||||
2020-07-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -100 | 26 838 | -0,37 | 296,48 | -29 648 | 7 956 930 |
2020-07-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -300 | 26 938 | -1,10 | 295,38 | -88 614 | 7 956 946 |
2020-07-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -800 | 27 238 | -2,85 | 294,57 | -235 656 | 8 023 498 |
2020-07-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -200 | 28 038 | -0,71 | 292,76 | -58 552 | 8 208 405 |
2020-07-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -100 | 28 238 | -0,35 | 290,65 | -29 065 | 8 207 375 |
2020-07-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -200 | 28 338 | -0,70 | 288,57 | -57 714 | 8 177 497 |
2020-07-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -100 | 28 538 | -0,35 | 286,57 | -28 657 | 8 178 135 |
2020-07-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -225 | 28 638 | -0,78 | 285,67 | -64 276 | 8 181 017 |
2020-07-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -100 | 28 863 | -0,35 | 284,28 | -28 428 | 8 205 174 |
2020-07-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 125 | 28 963 | 7,92 | 90,29 | 191 866 | 2 615 069 | |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -9 | 26 838 | -0,03 | 288,23 | -2 594 | 7 735 517 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -18 | 26 847 | -0,07 | 287,50 | -5 175 | 7 718 512 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -9 | 26 865 | -0,03 | 286,27 | -2 576 | 7 690 644 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -4 | 26 874 | -0,01 | 285,19 | -1 141 | 7 664 196 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -3 | 26 878 | -0,01 | 284,03 | -852 | 7 634 158 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -4 | 26 881 | -0,01 | 283,03 | -1 132 | 7 608 129 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -4 | 26 885 | -0,01 | 282,02 | -1 128 | 7 582 108 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -11 | 26 889 | -0,04 | 280,34 | -3 084 | 7 538 062 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 | 26 900 | 0,00 | 278,69 | -279 | 7 496 761 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -2 | 26 901 | -0,01 | 276,46 | -553 | 7 437 050 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -2 | 26 903 | -0,01 | 275,54 | -551 | 7 412 853 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 | 26 905 | 0,00 | 273,91 | -274 | 7 369 549 |
2020-05-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -1 304 | 14 338 | -8,34 | ||||
2020-05-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 304 | 26 838 | -4,63 | 286,00 | -372 944 | 7 675 668 |
2020-05-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 304 | 28 142 | 4,86 | 187,53 | 244 539 | 5 277 469 | |
2020-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -1 222 | 8 561 | -12,49 | ||||
2020-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -70 | 26 838 | -0,26 | 274,73 | -19 231 | 7 373 204 |
2020-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -420 | 26 908 | -1,54 | 273,96 | -115 063 | 7 371 716 |
2020-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -319 | 27 328 | -1,15 | 273,00 | -87 087 | 7 460 544 |
2020-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -140 | 27 647 | -0,50 | 271,64 | -38 030 | 7 510 031 |
2020-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -273 | 27 787 | -0,97 | 270,16 | -73 754 | 7 506 936 |
2020-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 222 | 28 060 | 4,55 | 155,57 | 190 107 | 4 365 294 | |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -2 330 | 6 990 | -25,00 | ||||
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -181 | 26 838 | -0,67 | 264,82 | -47 932 | 7 107 239 |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -554 | 27 019 | -2,01 | 262,48 | -145 414 | 7 091 947 |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -195 | 27 573 | -0,70 | 261,21 | -50 936 | 7 202 343 |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -700 | 27 768 | -2,46 | 260,16 | -182 112 | 7 224 123 |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -700 | 28 468 | -2,40 | 259,19 | -181 433 | 7 378 621 |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 330 | 29 168 | 8,68 | 86,52 | 201 592 | 2 523 615 | |
2020-05-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -2 125 | 2 125 | -50,00 | ||||
2020-05-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -100 | 26 838 | -0,37 | 258,15 | -25 815 | 6 928 230 |
2020-05-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -500 | 26 938 | -1,82 | 256,63 | -128 315 | 6 913 099 |
2020-05-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -680 | 27 438 | -2,42 | 255,44 | -173 699 | 7 008 763 |
2020-05-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -400 | 28 118 | -1,40 | 254,20 | -101 680 | 7 147 596 |
2020-05-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -300 | 28 518 | -1,04 | 252,70 | -75 810 | 7 206 499 |
2020-05-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -145 | 28 818 | -0,50 | 251,38 | -36 450 | 7 244 269 |
2020-05-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 125 | 28 963 | 7,92 | 90,29 | 191 866 | 2 615 069 | |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -480 | 26 838 | -1,76 | 238,30 | -114 384 | 6 395 495 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -320 | 27 318 | -1,16 | 236,26 | -75 603 | 6 454 151 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -640 | 27 638 | -2,26 | 234,77 | -150 253 | 6 488 573 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -320 | 28 278 | -1,12 | 232,89 | -74 525 | 6 585 663 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -330 | 28 598 | -1,14 | 231,62 | -76 435 | 6 623 869 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -938 | 28 928 | -3,14 | 230,07 | -215 806 | 6 655 465 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | -2 416 | 29 866 | -7,48 | 239,23 | -577 980 | 7 144 843 | |
2020-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -694 | 32 282 | -2,10 | 245,52 | -170 391 | 7 925 877 |
2020-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -416 | 32 976 | -1,25 | 244,64 | -101 770 | 8 067 249 |
2020-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -560 | 33 392 | -1,65 | 243,59 | -136 410 | 8 133 957 |
2020-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 098 | 33 952 | -3,13 | 242,64 | -266 419 | 8 238 113 |
2020-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -360 | 35 050 | -1,02 | 241,75 | -87 030 | 8 473 338 |
2020-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | -2 496 | 35 410 | -6,58 | 241,50 | -602 784 | 8 551 515 | |
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 344 | 37 906 | -3,42 | 248,52 | -334 011 | 9 420 399 |
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -2 499 | 39 250 | -5,99 | 247,62 | -618 802 | 9 719 085 |
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -3 783 | 41 749 | -8,31 | 246,52 | -932 585 | 10 291 963 |
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -6 232 | 45 532 | -12,04 | 245,62 | -1 530 704 | 11 183 570 |
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -2 102 | 51 764 | -3,90 | 244,67 | -514 296 | 12 665 098 |
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -922 | 53 866 | -1,68 | 243,42 | -224 433 | 13 112 062 |
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | -13 458 | 54 788 | -19,72 | 240,95 | -3 242 705 | 13 201 169 | |
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -1 223 | 9 783 | -11,11 | ||||
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -1 303 | 15 642 | -7,69 | ||||
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -154 | 68 246 | -0,23 | 242,47 | -37 340 | 16 547 608 |
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -300 | 68 400 | -0,44 | 240,79 | -72 237 | 16 470 036 |
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -585 | 68 700 | -0,84 | 239,58 | -140 154 | 16 459 146 |
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 487 | 69 285 | -2,10 | 238,77 | -355 051 | 16 543 179 |
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 223 | 70 772 | 1,76 | 155,57 | 190 262 | 11 010 000 | |
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 303 | 69 549 | 1,91 | 187,53 | 244 352 | 13 042 524 | |
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 10 323 | 68 246 | 17,82 | ||||
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 8 166 | 57 923 | 16,41 | ||||
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 18 204 | 49 757 | 57,69 | ||||
2020-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -2 330 | 9 320 | -20,00 | ||||
2020-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -400 | 31 553 | -1,25 | 233,03 | -93 212 | 7 352 796 |
2020-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 500 | 31 953 | -4,48 | 231,84 | -347 760 | 7 407 984 |
2020-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 350 | 33 453 | -3,88 | 231,20 | -312 120 | 7 734 334 |
2020-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -612 | 34 803 | -1,73 | 230,02 | -140 772 | 8 005 386 |
2020-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -574 | 35 415 | -1,59 | 229,07 | -131 486 | 8 112 514 |
2020-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 330 | 35 989 | 6,92 | 86,52 | 201 592 | 3 113 768 | |
2020-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -3 909 | 16 945 | -18,74 | ||||
2020-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | -1 344 | 33 659 | -3,84 | 231,21 | -310 746 | 7 782 297 | |
2020-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -3 909 | 35 003 | -10,05 | 238,65 | -932 883 | 8 353 466 |
2020-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 3 909 | 38 912 | 11,17 | 187,53 | 733 055 | 7 297 167 | |
2020-01-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -1 | 20 854 | 0,00 | ||||
2020-01-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 | 35 003 | 0,00 | 237,50 | -238 | 8 313 212 |
2020-01-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 | 35 004 | 0,00 | 187,53 | 188 | 6 564 300 | |
2020-01-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -2 125 | 4 250 | -33,33 | ||||
2020-01-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -300 | 35 003 | -0,85 | 228,99 | -68 697 | 8 015 337 |
2020-01-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -300 | 35 303 | -0,84 | 227,56 | -68 268 | 8 033 551 |
2020-01-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 225 | 35 603 | -3,33 | 226,42 | -277 364 | 8 061 231 |
2020-01-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -300 | 36 828 | -0,81 | 225,27 | -67 581 | 8 296 244 |
2020-01-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 125 | 37 128 | 6,07 | 90,29 | 191 866 | 3 352 287 | |
2020-01-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -4 250 | 0 | -100,00 | ||||
2020-01-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -329 | 35 003 | -0,93 | 224,11 | -73 732 | 7 844 522 |
2020-01-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 063 | 35 332 | -2,92 | 223,60 | -237 687 | 7 900 235 |
2020-01-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -398 | 36 395 | -1,08 | 222,67 | -88 623 | 8 104 075 |
2020-01-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 599 | 36 793 | -4,16 | 221,49 | -354 163 | 8 149 282 |
2020-01-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -461 | 38 392 | -1,19 | 220,69 | -101 738 | 8 472 730 |
2020-01-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -400 | 38 853 | -1,02 | 218,93 | -87 572 | 8 506 087 |
2020-01-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 4 250 | 39 253 | 12,14 | 122,45 | 520 412 | 4 806 530 | |
2019-11-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -84 | 35 003 | -0,24 | 205,95 | -17 300 | 7 208 868 |
2019-11-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -4 892 | 11 006 | -30,77 | ||||
2019-11-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -4 892 | 35 003 | -12,26 | 205,50 | -1 005 306 | 7 193 116 |
2019-11-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 4 892 | 39 895 | 13,98 | 155,57 | 761 048 | 6 206 465 | |
2019-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -2 330 | 11 650 | -16,67 | ||||
2019-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -600 | 35 003 | -1,69 | 201,37 | -120 822 | 7 048 554 |
2019-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 730 | 35 603 | -4,63 | 200,20 | -346 346 | 7 127 721 |
2019-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 330 | 37 333 | 6,66 | 86,52 | 201 592 | 3 230 051 | |
2019-10-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -4 250 | 4 250 | -50,00 | ||||
2019-10-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -4 250 | 35 003 | -10,83 | 177,80 | -755 650 | 6 223 533 |
2019-10-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 4 250 | 39 253 | 12,14 | 122,45 | 520 412 | 4 806 530 | |
2019-10-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -2 125 | 6 375 | -25,00 | ||||
2019-10-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -100 | 35 003 | -0,28 | 175,10 | -17 510 | 6 129 025 |
2019-10-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 136 | 35 103 | -3,13 | 174,46 | -198 187 | 6 124 069 |
2019-10-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -889 | 36 239 | -2,39 | 173,44 | -154 188 | 6 285 292 |
2019-10-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 125 | 37 128 | 6,07 | 90,29 | 191 866 | 3 352 287 | |
2019-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | 2 330 | 13 980 | 20,00 | ||||
2019-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 630 | 35 003 | -4,45 | 175,51 | -286 081 | 6 143 377 |
2019-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -700 | 36 633 | -1,88 | 174,74 | -122 318 | 6 401 250 |
2019-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 330 | 37 333 | 6,66 | 86,52 | 201 592 | 3 230 051 | |
2019-07-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -2 125 | 8 500 | -20,00 | ||||
2019-07-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -607 | 35 003 | -1,70 | 175,73 | -106 668 | 6 151 077 |
2019-07-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 518 | 35 610 | -4,09 | 175,09 | -265 787 | 6 234 955 |
2019-07-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 125 | 37 128 | 6,07 | 90,29 | 191 866 | 3 352 287 | |
2019-07-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | 4 250 | 8 500 | 100,00 | ||||
2019-07-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -300 | 35 003 | -0,85 | 182,43 | -54 729 | 6 385 597 |
2019-07-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 000 | 35 303 | -2,75 | 180,77 | -180 770 | 6 381 723 |
2019-07-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -500 | 36 303 | -1,36 | 179,23 | -89 615 | 6 506 587 |
2019-07-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -2 450 | 36 803 | -6,24 | 178,01 | -436 124 | 6 551 302 |
2019-07-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 4 250 | 39 253 | 12,14 | 122,45 | 520 412 | 4 806 530 | |
2019-05-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -83 | 35 003 | -0,24 | 165,41 | -13 729 | 5 789 846 |
2019-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -707 | 35 625 | -1,95 | 173,00 | -122 311 | 6 163 125 |
2019-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | 2 329 | 16 310 | 16,66 | ||||
2019-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -622 | 35 003 | -1,75 | 173,72 | -108 054 | 6 080 721 |
2019-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -500 | 36 332 | -1,36 | 171,71 | -85 855 | 6 238 568 |
2019-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Comon Stock |
S - Sale | X | -500 | 36 832 | -1,34 | 170,33 | -85 165 | 6 273 595 |
2019-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 329 | 37 332 | 6,65 | 86,52 | 201 505 | 3 229 965 | |
2019-04-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -2 125 | 10 625 | -16,67 | ||||
2019-04-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -4 250 | 12 750 | -25,00 | ||||
2019-04-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -400 | 35 003 | -1,13 | 184,42 | -73 768 | 6 455 253 |
2019-04-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -100 | 35 403 | -0,28 | 183,15 | -18 315 | 6 484 059 |
2019-04-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -600 | 35 503 | -1,66 | 182,24 | -109 344 | 6 470 067 |
2019-04-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -600 | 36 103 | -1,63 | 181,49 | -108 894 | 6 552 333 |
2019-04-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -425 | 36 703 | -1,14 | 179,84 | -76 432 | 6 600 668 |
2019-04-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 125 | 37 128 | 6,07 | 90,29 | 191 866 | 3 352 287 | |
2019-04-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -660 | 35 003 | -1,85 | 184,44 | -121 730 | 6 455 953 |
2019-04-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -300 | 35 663 | -0,83 | 183,26 | -54 978 | 6 535 601 |
2019-04-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 605 | 35 963 | -4,27 | 182,19 | -292 415 | 6 552 099 |
2019-04-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -815 | 37 568 | -2,12 | 181,31 | -147 768 | 6 811 454 |
2019-04-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -870 | 38 383 | -2,22 | 179,91 | -156 522 | 6 905 486 |
2019-04-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 4 250 | 39 253 | 12,14 | 122,45 | 520 412 | 4 806 530 | |
2019-02-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -400 | 35 003 | -1,13 | 188,54 | -75 416 | 6 599 466 |
2019-02-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -600 | 35 403 | -1,67 | 187,42 | -112 452 | 6 635 230 |
2019-02-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -4 624 | 36 003 | -11,38 | 186,79 | -863 717 | 6 725 000 |
2019-02-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -2 762 | 40 627 | -6,37 | 181,00 | -499 922 | 7 353 487 |
2019-02-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -5 480 | 43 389 | -11,21 | 180,36 | -988 373 | 7 825 640 |
2019-02-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -3 894 | 48 869 | -7,38 | 179,48 | -698 895 | 8 771 008 |
2019-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
A - Award | 20 855 | 20 855 | |||||
2019-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 8 166 | 52 763 | 18,31 | ||||
2019-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 8 438 | 44 597 | 23,34 | ||||
2019-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -2 330 | 18 639 | -11,11 | ||||
2019-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -2 330 | 36 159 | -6,05 | 189,19 | -440 813 | 6 840 921 |
2019-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 330 | 38 489 | 6,44 | 86,52 | 201 592 | 3 330 068 | |
2019-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -3 450 | 36 159 | -8,71 | 190,92 | -658 674 | 6 903 476 |
2019-01-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -3 668 | 15 898 | -18,75 | ||||
2019-01-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -3 668 | 39 609 | -8,48 | 195,00 | -715 260 | 7 723 755 |
2019-01-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 3 668 | 43 277 | 9,26 | 155,57 | 570 631 | 6 732 603 | |
2019-01-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | 2 125 | 12 750 | 20,00 | ||||
2019-01-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -2 125 | 39 609 | -5,09 | 186,71 | -396 759 | 7 395 396 |
2019-01-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 125 | 41 734 | 5,36 | 90,29 | 191 866 | 3 768 163 | |
2019-01-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | 4 250 | 17 000 | 33,33 | ||||
2019-01-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -4 250 | 39 609 | -9,69 | 165,90 | -705 075 | 6 571 133 |
2019-01-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 4 250 | 43 859 | 10,73 | 122,45 | 520 412 | 5 370 535 | |
2018-11-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -90 | 39 609 | -0,23 | 163,75 | -14 738 | 6 485 974 |
2018-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | 2 330 | 20 969 | 12,50 | ||||
2018-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -2 330 | 39 609 | -5,56 | 172,08 | -400 946 | 6 815 917 |
2018-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 330 | 41 939 | 5,88 | 86,52 | 201 592 | 3 628 562 | |
2018-10-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -2 125 | 14 875 | -12,50 | ||||
2018-10-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -2 125 | 39 609 | -5,09 | 177,20 | -376 550 | 7 018 715 |
2018-10-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 125 | 41 734 | 5,36 | 90,29 | 191 866 | 3 768 163 | |
2018-10-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -4 250 | 21 250 | -16,67 | ||||
2018-10-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -4 250 | 39 609 | -9,69 | 191,58 | -814 215 | 7 588 292 |
2018-10-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 4 250 | 43 859 | 10,73 | 122,45 | 520 412 | 5 370 535 | |
2018-08-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -2 330 | 23 299 | -9,09 | ||||
2018-08-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -2 330 | 39 609 | -5,56 | 174,20 | -405 886 | 6 899 888 |
2018-08-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 330 | 41 939 | 5,88 | 86,52 | 201 592 | 3 628 562 | |
2018-07-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -2 125 | 17 000 | -11,11 | ||||
2018-07-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -2 125 | 39 609 | -5,09 | 175,02 | -371 918 | 6 932 367 |
2018-07-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 125 | 41 734 | 5,36 | 90,29 | 191 866 | 3 768 163 | |
2018-07-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -4 250 | 25 500 | -14,29 | ||||
2018-07-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -4 250 | 39 609 | -9,69 | 168,38 | -715 615 | 6 669 363 |
2018-07-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 4 250 | 43 859 | 10,73 | 122,45 | 520 412 | 5 370 535 | |
2018-05-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -85 | 39 609 | -0,21 | 155,78 | -13 241 | 6 170 290 |
2018-05-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -2 330 | 25 629 | -8,33 | ||||
2018-05-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -2 330 | 39 609 | -5,56 | 149,50 | -348 335 | 5 921 546 |
2018-05-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 330 | 41 939 | 5,88 | 86,52 | 201 592 | 3 628 562 | |
2018-04-27 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -38 250 | 39 609 | -49,13 | 159,56 | -6 103 170 | 6 320 012 |
2018-04-27 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 38 250 | 77 859 | 96,57 | 122,45 | 4 683 712 | 9 533 835 | |
2018-04-27 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -2 125 | 19 125 | -10,00 | ||||
2018-04-27 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -300 | 39 609 | -0,75 | 156,36 | -46 908 | 6 193 263 |
2018-04-27 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -2 214 | 39 909 | -5,26 | 155,07 | -343 325 | 6 188 689 |
2018-04-27 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 125 | 42 123 | 5,31 | 90,29 | 191 866 | 3 803 286 | |
2018-04-27 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -38 250 | 29 750 | -56,25 | ||||
2018-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -12 136 | 39 998 | -23,28 | 153,41 | -1 861 784 | 6 136 093 |
2018-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
A - Award | 19 566 | 19 566 | |||||
2018-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 8 437 | 52 134 | 19,31 | ||||
2018-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 18 204 | 43 697 | 71,41 | ||||
2018-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -2 330 | 27 959 | -7,69 | ||||
2018-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -2 330 | 25 493 | -8,37 | 163,08 | -379 976 | 4 157 398 |
2018-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 330 | 27 823 | 9,14 | 86,52 | 201 592 | 2 407 246 | |
2018-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -3 450 | 25 493 | -11,92 | 174,11 | -600 680 | 4 438 586 |
2018-01-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -2 125 | 21 250 | -9,09 | ||||
2018-01-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -2 125 | 28 943 | -6,84 | 157,16 | -333 965 | 4 548 682 |
2018-01-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 125 | 31 068 | 7,34 | 90,29 | 191 866 | 2 805 130 | |
2017-11-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -2 330 | 30 289 | -7,14 | ||||
2017-11-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -2 330 | 28 809 | -7,48 | 149,50 | -348 335 | 4 306 946 |
2017-11-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 330 | 31 139 | 8,09 | 86,52 | 201 592 | 2 694 146 | |
2017-10-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -2 125 | 23 375 | -8,33 | ||||
2017-10-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -2 125 | 28 809 | -6,87 | 152,93 | -324 976 | 4 405 760 |
2017-10-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 125 | 30 934 | 7,38 | 90,29 | 191 866 | 2 793 031 | |
2017-08-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -2 330 | 32 619 | -6,67 | ||||
2017-08-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -2 330 | 28 809 | -7,48 | 155,72 | -362 828 | 4 486 137 |
2017-08-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 330 | 31 139 | 8,09 | 86,52 | 201 592 | 2 694 146 | |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -2 329 | 34 949 | -6,25 | ||||
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -8 500 | 25 500 | -25,00 | ||||
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -10 829 | 28 809 | -27,32 | 161,00 | -1 743 469 | 4 638 249 |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 329 | 39 638 | 6,24 | 86,52 | 201 505 | 3 429 480 | |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 8 500 | 37 309 | 29,50 | 90,29 | 767 465 | 3 368 630 | |
2017-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
A - Award | 37 278 | 37 278 | |||||
2017-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 18 204 | 28 554 | 175,88 | ||||
2017-02-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -3 450 | 10 350 | -25,00 | 85,98 | -296 631 | 889 893 |
2016-07-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
A - Award | 34 000 | 34 000 | |||||
2016-01-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
A - Award | 68 000 | 68 000 | |||||
2016-01-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 13 800 | 13 800 | 0,01 | 138 | 138 |